Clinical trial
A Double-blinded Randomized Controlled Trial With Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Between 24 and 32 Weeks Gestation
NCT00466128 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blinded Randomized Controlled Trial With Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Between 24 and 32 Weeks Gestation
- Lead sponsor
- Thomas Jefferson University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 30, 2007
- Completion date
- April 30, 2016
- Enrollment
- 116 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preterm premature rupture of membranes